Trial of a Treatment Algorithm for the Management of Crohn's Disease
Launched by UNIVERSITY OF WESTERN ONTARIO, CANADA · Dec 10, 2009
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract. During disease exacerbations, pharmacological or surgical intervention is usually needed to re-establish remission. Ideally, strategies should be employed to maintain patients in long-term remission while minimizing exposure to corticosteroids and reduce therapy-related toxicity.
Nevertheless, in reality many patients with CD do not receive effective therapy and their disease often remains active, leading to uncontrolled inflammation and complications from either the underlying disease or corticosteroids...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Documented diagnosis of Crohn's disease
- • Able to speak and understand English, French or Flemish
- • Access to a telephone or email/internet service
- • Written informed consent must be obtained and documented
- Exclusion Criteria:
- • Any conditions (e.g., history of alcohol or substance abuse) which in the opinion of the investigator , may interfere with the patients ability to comply with study procedures
- • Participating in other investigational studies
Trial Officials
Brian G Feagan, MD
Principal Investigator
Robarts Research Institute - University of Western Ontario
About University Of Western Ontario, Canada
The University of Western Ontario, located in Canada, is a prestigious academic institution dedicated to advancing knowledge and innovation in various fields, including health sciences. With a strong emphasis on research excellence, the university actively engages in clinical trials to explore new therapies, improve patient outcomes, and contribute to the global body of medical knowledge. Through collaboration with healthcare professionals and industry partners, the University of Western Ontario fosters a rigorous and ethical research environment, aiming to translate scientific discoveries into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials